| 6-K |
Open Document
|
Open Filing |
6-K |
Sep 15, 2025 |
Sep 15, 2025 |
001-39530 |
| 6-K |
Open Document
| Data
|
Open Filing |
6-K |
Sep 15, 2025 |
Jul 31, 2025 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Sep 10, 2025 |
Sep 10, 2025 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Sep 3, 2025 |
Sep 3, 2025 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Sep 2, 2025 |
Sep 2, 2025 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Aug 27, 2025 |
Aug 27, 2025 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Aug 6, 2025 |
Aug 6, 2025 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Aug 1, 2025 |
Aug 1, 2025 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Jul 29, 2025 |
Jul 29, 2025 |
001-39530 |
| 20-F |
Open Document
| Data
|
Open Filing |
20-F |
Jul 29, 2025 |
Apr 30, 2025 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Jul 24, 2025 |
Jul 24, 2025 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Jul 21, 2025 |
Jul 21, 2025 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Jul 14, 2025 |
Jul 14, 2025 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Jul 7, 2025 |
Jul 7, 2025 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Jul 3, 2025 |
Jul 3, 2025 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Jun 24, 2025 |
Jun 24, 2025 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Jun 12, 2025 |
Jun 12, 2025 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Jun 5, 2025 |
Jun 5, 2025 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
May 21, 2025 |
May 21, 2025 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
May 12, 2025 |
May 12, 2025 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Apr 11, 2025 |
Apr 11, 2025 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Apr 10, 2025 |
Apr 9, 2025 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Mar 28, 2025 |
Mar 28, 2025 |
001-39530 |
| 6-K |
Open Document
| Data
|
Open Filing |
6-K |
Mar 28, 2025 |
Jan 31, 2025 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Mar 13, 2025 |
Mar 13, 2025 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Mar 12, 2025 |
Mar 12, 2025 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Feb 24, 2025 |
Feb 24, 2025 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Feb 3, 2025 |
Feb 3, 2025 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Jan 27, 2025 |
Jan 27, 2025 |
001-39530 |
| SCHEDULE 13G/A |
Open Document
|
Open Filing |
|
Jan 24, 2025 |
|
005-94108 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Jan 22, 2025 |
Jan 22, 2025 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Jan 17, 2025 |
Jan 17, 2025 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Jan 3, 2025 |
Jan 2, 2025 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Dec 23, 2024 |
Dec 23, 2024 |
001-39530 |
| 20-F/A |
Open Document
|
Open Filing |
20-F/A |
Dec 10, 2024 |
Dec 10, 2024 |
001-39530 |
| 6-K |
Open Document
| Data
|
Open Filing |
6-K |
Dec 10, 2024 |
Oct 31, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Dec 10, 2024 |
Dec 10, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Dec 3, 2024 |
Dec 3, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Nov 18, 2024 |
Nov 15, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Nov 13, 2024 |
Nov 13, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Nov 4, 2024 |
Nov 4, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Oct 28, 2024 |
Oct 28, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Oct 24, 2024 |
Oct 23, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Oct 21, 2024 |
Oct 21, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Oct 11, 2024 |
Oct 10, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Oct 10, 2024 |
Oct 10, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Oct 2, 2024 |
Oct 2, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Sep 26, 2024 |
Sep 26, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Sep 23, 2024 |
Sep 20, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Sep 18, 2024 |
Sep 17, 2024 |
001-39530 |
| 6-K/A |
Open Document
|
Open Filing |
FORM 6-K/A |
Sep 16, 2024 |
Aug 23, 2024 |
001-39530 |
| 6-K |
Open Document
| Data
|
Open Filing |
6-K |
Sep 16, 2024 |
Jul 31, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Sep 16, 2024 |
Sep 16, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Sep 10, 2024 |
Sep 9, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Aug 26, 2024 |
Aug 26, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Aug 26, 2024 |
Aug 23, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Aug 19, 2024 |
Aug 19, 2024 |
001-39530 |
| EFFECT |
Open Document
|
Open Filing |
|
Aug 16, 2024 |
|
333-281312 |
| F-3 |
Open Document
|
Open Filing |
FORM F-3 |
Aug 6, 2024 |
|
333-281312 |
| D |
Open Document
|
Open Filing |
|
Jul 30, 2024 |
|
021-520087 |
| 424B5 |
Open Document
|
Open Filing |
FORM 424B5 |
Jul 30, 2024 |
|
333-273197 |
| 20-F |
Open Document
| Data
|
Open Filing |
20-F |
Jul 29, 2024 |
Apr 30, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Jul 29, 2024 |
Jul 29, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Jul 24, 2024 |
Jul 23, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Jul 17, 2024 |
Jul 16, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Jul 15, 2024 |
Jul 15, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Jun 27, 2024 |
Jun 27, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Jun 25, 2024 |
Jun 25, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Jun 12, 2024 |
Jun 12, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Jun 10, 2024 |
Jun 10, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Jun 4, 2024 |
Jun 3, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Mar 28, 2024 |
Mar 28, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Mar 20, 2024 |
Mar 20, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Mar 14, 2024 |
Mar 14, 2024 |
001-39530 |
| 6-K |
Open Document
| Data
|
Open Filing |
6-K |
Mar 14, 2024 |
Jan 31, 2024 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Mar 7, 2024 |
Mar 7, 2024 |
001-39530 |
| SC 13G |
Open Document
|
Open Filing |
|
Feb 27, 2024 |
|
005-94108 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Feb 23, 2024 |
Feb 23, 2024 |
001-39530 |
| 424B5 |
Open Document
|
Open Filing |
FORM 424B5 |
Feb 23, 2024 |
|
333-273197 |
| 6-K/A |
Open Document
| Data
|
Open Filing |
FORM 6-K/A |
Feb 15, 2024 |
Oct 31, 2023 |
001-39530 |
| SC 13G/A |
Open Document
|
Open Filing |
SCHEDULE 13G AMENDMENT |
Jan 10, 2024 |
|
005-94108 |
| SC 13G |
Open Document
|
Open Filing |
SCHEDULE 13G |
Jan 10, 2024 |
|
005-94108 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Dec 14, 2023 |
Dec 13, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Dec 14, 2023 |
Oct 31, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Dec 14, 2023 |
Dec 14, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Dec 8, 2023 |
Dec 8, 2023 |
001-39530 |
| 424B5 |
Open Document
|
Open Filing |
FORM 424B5 |
Dec 7, 2023 |
|
333-273197 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Dec 6, 2023 |
Dec 5, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Dec 6, 2023 |
Dec 6, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Dec 6, 2023 |
Dec 5, 2023 |
001-39530 |
| 424B5 |
Open Document
|
Open Filing |
FORM 424B5 |
Dec 5, 2023 |
|
333-273197 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Nov 27, 2023 |
Nov 27, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Nov 16, 2023 |
Nov 9, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Nov 13, 2023 |
Nov 13, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Oct 25, 2023 |
Oct 25, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Oct 23, 2023 |
Oct 23, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Oct 20, 2023 |
Nov 9, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Sep 26, 2023 |
Sep 22, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Sep 25, 2023 |
Sep 22, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Sep 19, 2023 |
Sep 19, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Sep 18, 2023 |
Sep 15, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Sep 14, 2023 |
Sep 14, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Sep 14, 2023 |
Sep 14, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Sep 13, 2023 |
Sep 6, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Sep 8, 2023 |
Sep 8, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Sep 5, 2023 |
Sep 5, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Aug 16, 2023 |
Aug 15, 2023 |
001-39530 |
| 424B5 |
Open Document
|
Open Filing |
FORM 424B5 |
Aug 16, 2023 |
|
333-273197 |
| 6-K/A |
Open Document
|
Open Filing |
FORM 6-K/A |
Aug 14, 2023 |
Aug 9, 2023 |
001-39530 |
| 6-K/A |
Open Document
|
Open Filing |
FORM 6-K/A |
Aug 14, 2023 |
Dec 13, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Aug 9, 2023 |
Aug 9, 2023 |
001-39530 |
| EFFECT |
Open Document
|
Open Filing |
|
Jul 14, 2023 |
|
333-273197 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Jul 14, 2023 |
Jul 14, 2023 |
001-39530 |
| CORRESP |
Open Document
|
Open Filing |
|
Jul 13, 2023 |
|
|
| UPLOAD |
Open Document
|
Open Filing |
|
Jul 12, 2023 |
|
|
| F-3 |
Open Document
|
Open Filing |
FORM F-3 |
Jul 11, 2023 |
|
333-273197 |
| 40-F |
Open Document
| Data
|
Open Filing |
40-F |
Jul 10, 2023 |
Apr 30, 2023 |
001-39530 |
| SC 13D |
Open Document
|
Open Filing |
|
Jul 7, 2023 |
|
005-94108 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Jul 7, 2023 |
Jul 7, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Jun 29, 2023 |
Jun 29, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Jun 13, 2023 |
Jun 13, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Jun 6, 2023 |
Jun 6, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
May 30, 2023 |
May 30, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
May 17, 2023 |
May 17, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Apr 24, 2023 |
Feb 2, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Mar 30, 2023 |
Mar 28, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Mar 30, 2023 |
Mar 30, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Mar 27, 2023 |
Mar 27, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Mar 23, 2023 |
Mar 23, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Mar 16, 2023 |
Mar 16, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Mar 16, 2023 |
Mar 16, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Mar 15, 2023 |
Mar 15, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Mar 7, 2023 |
Mar 7, 2023 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Jan 5, 2023 |
Dec 13, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Dec 15, 2022 |
Dec 15, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Dec 15, 2022 |
Dec 15, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Dec 8, 2022 |
Dec 8, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Dec 5, 2022 |
Dec 5, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Nov 30, 2022 |
Nov 30, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Nov 22, 2022 |
Nov 22, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Nov 17, 2022 |
Dec 13, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Nov 2, 2022 |
Apr 30, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Oct 17, 2022 |
Oct 14, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Oct 12, 2022 |
Oct 12, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Sep 14, 2022 |
Sep 14, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Sep 14, 2022 |
Sep 14, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Sep 14, 2022 |
Sep 14, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Sep 8, 2022 |
Sep 8, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Aug 29, 2022 |
Aug 29, 2022 |
001-39530 |
| 40-F |
Open Document
| Data
|
Open Filing |
FORM 40-F |
Jul 29, 2022 |
Apr 30, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Jul 29, 2022 |
Jul 29, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Jul 26, 2022 |
Jul 26, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Jul 12, 2022 |
Jul 12, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
May 9, 2022 |
May 9, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Apr 25, 2022 |
Apr 22, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Apr 20, 2022 |
Apr 20, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Apr 14, 2022 |
Mar 29, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Apr 14, 2022 |
Apr 14, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
FORM 6-K |
Apr 12, 2022 |
Feb 19, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Mar 29, 2022 |
Mar 29, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Mar 16, 2022 |
Mar 16, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
FY22 Q3 6-K |
Mar 16, 2022 |
Mar 16, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Mar 14, 2022 |
Mar 9, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Mar 14, 2022 |
Mar 14, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Mar 8, 2022 |
Mar 8, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Jan 31, 2022 |
Jan 31, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Jan 18, 2022 |
Jan 18, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Jan 18, 2022 |
Jan 17, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Jan 11, 2022 |
Jan 11, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Jan 3, 2022 |
Jan 3, 2022 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Dec 20, 2021 |
Dec 20, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IPA FY22 Q2 6-K |
Dec 13, 2021 |
Dec 13, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Dec 13, 2021 |
Dec 13, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Dec 7, 2021 |
Dec 7, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Nov 30, 2021 |
Nov 30, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Nov 24, 2021 |
Nov 24, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Nov 12, 2021 |
Nov 12, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Nov 10, 2021 |
Nov 9, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Oct 29, 2021 |
Oct 29, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. FORM 6-K |
Oct 14, 2021 |
Oct 13, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Oct 13, 2021 |
Oct 13, 2021 |
001-39530 |
| SUPPL |
Open Document
|
Open Filing |
SUPPL |
Oct 13, 2021 |
|
333-249957 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Oct 7, 2021 |
Oct 7, 2021 |
001-39530 |
| 40-F/A |
Open Document
| Data
|
Open Filing |
40-F/A |
Sep 29, 2021 |
Apr 30, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Sep 9, 2021 |
Sep 9, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IPA FY22 Q1 6-K FILING |
Sep 9, 2021 |
Sep 9, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Sep 8, 2021 |
Sep 8, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Sep 7, 2021 |
Sep 7, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. FORM 6-K |
Sep 3, 2021 |
Sep 3, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Aug 4, 2021 |
Aug 4, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Jul 28, 2021 |
Jul 28, 2021 |
001-39530 |
| 40-F |
Open Document
|
Open Filing |
40-F |
Jul 28, 2021 |
Apr 30, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Jul 22, 2021 |
Jul 22, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Jul 15, 2021 |
Jul 15, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Jun 22, 2021 |
Jun 22, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Jun 17, 2021 |
Jun 17, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Jun 15, 2021 |
Jun 15, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. FORM 6-K |
Jun 3, 2021 |
Jun 2, 2021 |
001-39530 |
| S-8 |
Open Document
|
Open Filing |
S-8 |
Jun 2, 2021 |
|
333-256730 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
May 25, 2021 |
May 25, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
May 20, 2021 |
May 20, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Apr 21, 2021 |
Apr 21, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Apr 8, 2021 |
Apr 8, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Mar 25, 2021 |
Mar 25, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Mar 18, 2021 |
Mar 18, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. FORM 6-K |
Mar 18, 2021 |
Mar 17, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Mar 16, 2021 |
Mar 16, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Mar 4, 2021 |
Mar 4, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Feb 19, 2021 |
Feb 19, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Feb 11, 2021 |
Feb 10, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Feb 8, 2021 |
Feb 8, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Feb 4, 2021 |
Feb 4, 2021 |
001-39530 |
| SUPPL |
Open Document
|
Open Filing |
SUPPL |
Feb 4, 2021 |
|
333-249957 |
| FWP |
Open Document
|
Open Filing |
FWP |
Feb 4, 2021 |
|
333-249957 |
| FWP |
Open Document
|
Open Filing |
FWP |
Feb 4, 2021 |
|
333-249957 |
| SUPPL |
Open Document
|
Open Filing |
SUPPL |
Feb 3, 2021 |
|
333-249957 |
| 6-K |
Open Document
|
Open Filing |
6-K |
Feb 3, 2021 |
Feb 1, 2021 |
001-39530 |
| EFFECT |
Open Document
|
Open Filing |
|
Jan 11, 2021 |
|
333-249957 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Jan 7, 2021 |
Jan 6, 2021 |
001-39530 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Jan 6, 2021 |
Jan 6, 2021 |
001-39530 |
| F-10/A |
Open Document
|
Open Filing |
F-10/A |
Jan 5, 2021 |
|
333-249957 |
| 6-K |
Open Document
|
Open Filing |
IMMUNOPRECISE ANTIBODIES LTD. 6-K |
Dec 30, 2020 |
Dec 30, 2020 |
001-39530 |
| SEC STAFF ACTION |
Open Document
|
Open Filing |
|
Dec 29, 2020 |
|
|
| 40FR12B/A |
Open Document
|
Open Filing |
40FR12B/A |
Dec 28, 2020 |
|
001-39530 |
| CERT |
Open Document
|
Open Filing |
|
Dec 28, 2020 |
|
001-39530 |
| 40FR12B/A |
Open Document
|
Open Filing |
40FR12B/A |
Dec 22, 2020 |
|
001-39530 |
| F-X |
Open Document
|
Open Filing |
F-X |
Nov 9, 2020 |
|
333-249957 |
| F-10 |
Open Document
|
Open Filing |
F-10 |
Nov 9, 2020 |
|
333-249957 |
| 40FR12B/A |
Open Document
|
Open Filing |
40FR12B/A |
Nov 4, 2020 |
|
001-39530 |
| 40FR12B/A |
Open Document
|
Open Filing |
40FR12B/A |
Oct 2, 2020 |
|
001-39530 |
| F-X |
Open Document
|
Open Filing |
F-X |
Sep 16, 2020 |
|
001-39530 |
| 40FR12B |
Open Document
|
Open Filing |
40FR12B |
Sep 16, 2020 |
|
001-39530 |
| D |
Open Document
|
Open Filing |
|
Oct 9, 2018 |
|
021-322998 |
| D |
Open Document
|
Open Filing |
|
Jul 9, 2018 |
|
021-316275 |
| D |
Open Document
|
Open Filing |
|
Aug 31, 2017 |
|
021-293834 |